Temozolomide: all 659 studies that test it

Page 7 of 7. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma MultiformeCompletedNCT00068952Phase 3
• Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous SystemTerminatedNCT00068666Phase 2
• Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
• Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00052455Phase 3
• Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00049387Phase 1
• Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain MetastasesCompletedNCT00049361Phase 2
• Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00047294Phase 2
• Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain TumorsCompletedNCT00039494Phase 2
• Temozolomide and SCH66336 for Recurrent Glioblastoma MultiformeCompletedNCT00038493Phase 2
• Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)TerminatedNCT00034697Phase 2
• Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaStatus unknownNCT00033709Phase 2
• Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic OligoastrocytomasCompletedNCT00033280Phase 2
• Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine GliomaCompletedNCT00028795Phase 2
• Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00027742Phase 2
• Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaCompletedNCT00027625Phase 1
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerCompletedNCT00025558Phase 1
• Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung CancerCompletedNCT00022711Phase 2
• Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma MultiformeWithdrawnNCT00021307Phase 1/2
• Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the BrainTerminatedNCT00020839Phase 3
• Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
• Biological Therapy and Temozolomide in Treating Patients With Metastatic MelanomaStatus unknownNCT00016055Phase 1
• Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid TumorsCompletedNCT00014261Phase 1
• Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma MultiformeStatus unknownNCT00014105Phase 1/2
• Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With SurgeryCompletedNCT00014092Phase 2
• Temozolomide in Treating Patients With Solid Tumors That Have Spread to the BrainCompletedNCT00012116Phase 2
• Temozolomide in Treating Patients With Metastatic Non-small Cell Lung CancerCompletedNCT00006877Phase 2
• Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic GliomaCompletedNCT00006474Phase 1
• Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
• Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00006353Phase 3
• Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade GliomaWithdrawnNCT00006263Phase 2
• Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to CisplatinCompletedNCT00006043Phase 2
• Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
• Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaCompletedNCT00006024Phase 1
• Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS TumorsCompletedNCT00005955Phase 2
• Temozolomide in Treating Patients With Brain MetastasesCompletedNCT00005954Phase 2
• Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsCompletedNCT00005952Phase 1/2
• Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaCompletedNCT00005951Phase 1
• Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
• Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaTerminatedNCT00005812Phase 2
• Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00005637Phase 1
• S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal TumorsCompletedNCT00005597Phase 2
• Temozolomide in Treating Women With Advanced Breast CancerStatus unknownNCT00005054Phase 2
• Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00005037Phase 2
• Temozolomide in Treating Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT00004204Phase 2
• Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00004200Phase 2
• Temozolomide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004113Phase 2
• Temozolomide in Treating Patients With Mycosis Fungoides or Sezary SyndromeTerminatedNCT00004106Phase 2
• Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain TumorCompletedNCT00004068Phase 2
• Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic MelanomaStatus unknownNCT00003747Phase 1
• Temozolomide in Treating Patients With Recurrent Oligodendroglial TumorsCompletedNCT00003731Phase 2
• Temozolomide in Treating Patients With Advanced Soft Tissue SarcomaStatus unknownNCT00003718Phase 2
• Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00003708Phase 1
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT00003567Phase 1
• Temozolomide in Treating Patients With Progressive Low-Grade GliomaCompletedNCT00003466Phase 2
• Temozolomide in Treating Patients With Anaplastic OligodendrogliomaCompletedNCT00003465Phase 2
• Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma MultiformeCompletedNCT00003464Phase 2
• Temozolomide in Treating Patients With Recurrent Oligodendroglial TumorsCompletedNCT00003304Phase 2
• Temozolomide and Carmustine in Treating Patients With Anaplastic GliomaCompletedNCT00003176Phase 2
• Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung CancerCompletedNCT00003062Phase 2

← Temozolomide overview